Selected research
Industry Research
Metolazone Industry Research Report 2026
Market perspective
The global Metolazone market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Metolazone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Metolazone is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Metolazone is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Metolazone include Teva Pharmaceuticals, Novartis, Mylan Pharmaceuticals, Mylan, Watson Laboratories, UCB, Roxane Laboratories, Lannett and Gd Searle, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Metolazone market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Metolazone Market by Company
Teva Pharmaceuticals
Novartis
Mylan Pharmaceuticals
Mylan
Watson Laboratories
UCB
Roxane Laboratories
Lannett
Gd Searle
Metolazone Segment by Type
5mg
2.5mg
10mg
Metolazone Segment by Application
Edema
Mild Hypertension
Moderate Hypertension
Metolazone Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metolazone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Metolazone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metolazone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Metolazone manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Metolazone by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Metolazone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 5mg
- 2.5mg
- 10mg
Applications
- Edema
- Mild Hypertension
- Moderate Hypertension
Companies covered
- Teva Pharmaceuticals
- Novartis
- Mylan Pharmaceuticals
- Mylan
- Watson Laboratories
- UCB
- Roxane Laboratories
- Lannett
- Gd Searle
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Metolazone Market Size (2021-2032)
- 2.2.2 Global Metolazone Sales (2021-2032)
- 2.2.3 Global Metolazone Market Average Price (2021-2032)
- 2.3 Metolazone by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 5mg
- 2.3.3 2.5mg
- 2.3.4 10mg
- 2.4 Metolazone by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Edema
- 2.4.3 Mild Hypertension
- 2.4.4 Moderate Hypertension
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Metolazone Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Metolazone Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Metolazone Revenue of Manufacturers (2021-2026)
- 3.4 Global Metolazone Average Price by Manufacturers (2021-2026)
- 3.5 Global Metolazone Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Metolazone, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Metolazone, Product Type & Application
- 3.8 Global Manufacturers of Metolazone, Established Date
- 3.9 Global Metolazone Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva Pharmaceuticals
- 4.1.1 Teva Pharmaceuticals Company Information
- 4.1.2 Teva Pharmaceuticals Business Overview
- 4.1.3 Teva Pharmaceuticals Metolazone Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Pharmaceuticals Metolazone Product Portfolio
- 4.1.5 Teva Pharmaceuticals Recent Developments
- 4.2 Novartis
- 4.2.1 Novartis Company Information
- 4.2.2 Novartis Business Overview
- 4.2.3 Novartis Metolazone Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Novartis Metolazone Product Portfolio
- 4.2.5 Novartis Recent Developments
- 4.3 Mylan Pharmaceuticals
- 4.3.1 Mylan Pharmaceuticals Company Information
- 4.3.2 Mylan Pharmaceuticals Business Overview
- 4.3.3 Mylan Pharmaceuticals Metolazone Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Mylan Pharmaceuticals Metolazone Product Portfolio
- 4.3.5 Mylan Pharmaceuticals Recent Developments
- 4.4 Mylan
- 4.4.1 Mylan Company Information
- 4.4.2 Mylan Business Overview
- 4.4.3 Mylan Metolazone Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Mylan Metolazone Product Portfolio
- 4.4.5 Mylan Recent Developments
- 4.5 Watson Laboratories
- 4.5.1 Watson Laboratories Company Information
- 4.5.2 Watson Laboratories Business Overview
- 4.5.3 Watson Laboratories Metolazone Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Watson Laboratories Metolazone Product Portfolio
- 4.5.5 Watson Laboratories Recent Developments
- 4.6 UCB
- 4.6.1 UCB Company Information
- 4.6.2 UCB Business Overview
- 4.6.3 UCB Metolazone Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 UCB Metolazone Product Portfolio
- 4.6.5 UCB Recent Developments
- 4.7 Roxane Laboratories
- 4.7.1 Roxane Laboratories Company Information
- 4.7.2 Roxane Laboratories Business Overview
- 4.7.3 Roxane Laboratories Metolazone Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Roxane Laboratories Metolazone Product Portfolio
- 4.7.5 Roxane Laboratories Recent Developments
- 4.8 Lannett
- 4.8.1 Lannett Company Information
- 4.8.2 Lannett Business Overview
- 4.8.3 Lannett Metolazone Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Lannett Metolazone Product Portfolio
- 4.8.5 Lannett Recent Developments
- 4.9 Gd Searle
- 4.9.1 Gd Searle Company Information
- 4.9.2 Gd Searle Business Overview
- 4.9.3 Gd Searle Metolazone Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Gd Searle Metolazone Product Portfolio
- 4.9.5 Gd Searle Recent Developments
5 Global Metolazone Market Scenario by Region
- 5.1 Global Metolazone Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Metolazone Sales by Region: 2021-2032
- 5.2.1 Global Metolazone Sales by Region: 2021-2026
- 5.2.2 Global Metolazone Sales by Region: 2027-2032
- 5.3 Global Metolazone Revenue by Region: 2021-2032
- 5.3.1 Global Metolazone Revenue by Region: 2021-2026
- 5.3.2 Global Metolazone Revenue by Region: 2027-2032
- 5.4 North America Metolazone Market Facts & Figures by Country
- 5.4.1 North America Metolazone Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Metolazone Sales by Country (2021-2032)
- 5.4.3 North America Metolazone Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Metolazone Market Facts & Figures by Country
- 5.5.1 Europe Metolazone Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Metolazone Sales by Country (2021-2032)
- 5.5.3 Europe Metolazone Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Metolazone Market Facts & Figures by Country
- 5.6.1 Asia Pacific Metolazone Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Metolazone Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Metolazone Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Metolazone Market Facts & Figures by Country
- 5.7.1 South America Metolazone Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Metolazone Sales by Country (2021-2032)
- 5.7.3 South America Metolazone Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Metolazone Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Metolazone Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Metolazone Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Metolazone Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Metolazone Sales by Type (2021-2032)
- 6.1.1 Global Metolazone Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Metolazone Sales Market Share by Type (2021-2032)
- 6.2 Global Metolazone Revenue by Type (2021-2032)
- 6.2.1 Global Metolazone Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Metolazone Revenue Market Share by Type (2021-2032)
- 6.3 Global Metolazone Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Metolazone Sales by Application (2021-2032)
- 7.1.1 Global Metolazone Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Metolazone Sales Market Share by Application (2021-2032)
- 7.2 Global Metolazone Revenue by Application (2021-2032)
- 7.2.1 Global Metolazone Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Metolazone Revenue Market Share by Application (2021-2032)
- 7.3 Global Metolazone Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Metolazone Value Chain Analysis
- 8.1.1 Metolazone Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Metolazone Production Mode & Process
- 8.2 Metolazone Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Metolazone Distributors
- 8.2.3 Metolazone Customers
9 Global Metolazone Analyzing Market Dynamics
- 9.1 Metolazone Industry Trends
- 9.2 Metolazone Industry Drivers
- 9.3 Metolazone Industry Opportunities and Challenges
- 9.4 Metolazone Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst